S&P 500
7,540.00
-0.13%
Dow Jones
52,493.20
-0.04%
Nasdaq 100
29,699.60
-0.17%
Russell 2000
2,985.21
-0.18%
FTSE 100
10,485.30
+0.05%
Nikkei 225
68,864.70
-0.24%

Investing

Pre-Market Stock News (June 27, 2007)

Photo of Douglas A. McIntyre
By Douglas A. McIntyre Published

(ANDW) Andrew Corp being acquired for $15.00 per share.
(APOG) Apogee Enterprises $0.34 EPS vs $0.23e; unsure if comparable.
(AUTH) AuthenTec priced its 7.5M share IPO at the top of the $9.00 to $11.00 range for 7.5 million shares.
(BAY) Bayer AG and Onyx submit supplemental new drug application for Nexavar to treat liver cancer.
(CTV) Commscope raised guidance.
(GTRC) Guitar Center being acquired by Bain Capital for $63.00 per share.
(ISTA) ISTA Pharmaceuticals will raise $36.75 million in private placement.
(JSDA) Jones Soda announced exclusive formula use pact in Japan.
(KVHI) KVH Industries announced that Monaco Coach will add the KVH TracVision R-series of mobile satellite TV systems to their new 2008 vehicles.
(NKE) Nike $0.86 EPS vs $0.86e.
(NUVO) Nuvelo lost Bayer as R&D partner in stroke trials.
(ORCL) Oracle $0.37 EPS vs $0.35e.
(PAYX) Paychex reports earnings after close: $0.36 EPS and $496.3M revenue expected.
(RYAAY) Ryanair blocked by EU in bid to buy Aer Lingus.
(SCOR) comScore priced its 5.3 million share IPO at $16.50 per share.
(SMSC) $0.29 EPS vs $0.25e.
(SQNM) Sequenom announced it will develop HPVtest and other diagnostics with SensiGEn LLC.
(TASR) Taser announced a suit in St. Louis against the company was voluntarily dismissed.
(TOPP) Topps Co. said Upper Deck has initiated a $10.75 per share tender.
(YMI) YM BioSciences received FDA Clearance for an IND for its fentanyl-based pain product.
(YUM) Yum! Brands trades ex-split to reflect a 2-1 stock split.

Jon C. Ogg
June 27, 2007

Jon Ogg can be reached at [email protected]; he does not own securities in the companies he covers.

Contact [email protected] for any questions or corrections.

Follow 24/7 Wall St. on Google
Photo of Douglas A. McIntyre
About the Author Douglas A. McIntyre →

Douglas A. McIntyre is the co-founder, chief executive officer and editor in chief of 24/7 Wall St. and 24/7 Tempo. He has held these jobs since 2006.

McIntyre has written thousands of articles for 24/7 Wall St. He is an expert on corporate finance, the automotive industry, media companies and international finance. He has edited articles on national demographics, sports, personal income and travel.

His work has been quoted or mentioned in The New York Times, The Wall Street Journal, Los Angeles Times, The Washington Post, NBC News, Time, The New Yorker, HuffPost USA Today, Business Insider, Yahoo, AOL, MarketWatch, The Atlantic, Bloomberg, New York Post, Chicago Tribune, Forbes, The Guardian and many other major publications. McIntyre has been a guest on CNBC, the BBC and television and radio stations across the country.

A magna cum laude graduate of Harvard College, McIntyre also was president of The Harvard Advocate. Founded in 1866, the Advocate is the oldest college publication in the United States.

TheStreet.com, Comps.com and Edgar Online are some of the public companies for which McIntyre served on the board of directors. He was a Vicinity Corporation board member when the company was sold to Microsoft in 2002. He served on the audit committees of some of these companies.

McIntyre has been the CEO of FutureSource, a provider of trading terminals and news to commodities and futures traders. He was president of Switchboard, the online phone directory company. He served as chairman and CEO of On2 Technologies, the video compression company that provided video compression software for Adobe’s Flash. Google bought On2 in 2009.

Continue Reading

Paul Ausick |

Bausch + Lomb Nabs ISTA (ISTA, VRX)

Privately held Bausch + Lomb Inc. has made ISTA Pharmaceuticals Inc. (NASDAQ: ISTA) an offer it can’t refuse. The eye…

Paul Ausick |

Deadline Extended in Valeant Offer for ISTA (VRX, ISTA)

Two weeks ago Valeant Pharmaceuticals International, Inc. (NYSE: VRX) made an unsolicited all-cash offer of $6.50/share for ISTA Pharmaceuticals, Inc.…

Bayer Stumps Up $66 Billion to Acquire Monsanto
Paul Ausick |

Bayer Stumps Up $66 Billion to Acquire Monsanto

One of the most talked about deals of the year has been the acquisition of Monsanto by German chemical giant…

Paul Ausick |

Morning Movers (ISTA, MRT, CALL, QTWW, CVC, RIMM, SINA, STEM)

There are several stocks trading more heavily than usual this morning, and also experiencing large gains or drops in share…

Douglas A. McIntyre |

Pre-Market Stock News (MAR 6, 2007)

(AQNT) aQuantive announced the acquisition of Duke, an independent interactive agency based in Paris, for its Razorfish unit.(BEAS) BEA is…

Douglas A. McIntyre |

Topps Acquired by Eisner-led Group (TOPP, CLCT)

One merger that seems very peculiar this morning is that of Topps (TOPP-NASDAQ).  This is the baseball card and sports…

Paul Ausick |

Valeant Launches Hostile Bid for ISTA (VRX, ISTA)

Valeant Pharmaceuticals International, Inc. (NYSE: VRX) has made an unsolicited all-cash offer of $6.50/share for ISTA Pharmaceuticals, Inc. (NASDAQ: ISTA),…

Monsanto (Predictably) Rebuffs Bayer
Paul Ausick |

Monsanto (Predictably) Rebuffs Bayer

Bayer said Tuesday that it was not surprised that its $62 billion offer to acquire Monsanto was declined, but the…

Douglas A. McIntyre |

Pre-Market Stock News (June 19, 2007)

(ALTH) Allos Therapeutics trading down 20% after its Phase III study of Efaproxyn failed to meet primary endpoint of improvement…

Top Gaining Stocks

Hewlett Packard Enterprise
HPE • Vol: 26,431,700
Norwegian Cruise Line
NCLH • Vol: 17,600,839
Lam Research
LRCX • Vol: 12,118,424
Invesco
IVZ • Vol: 4,557,369
AMD
AMD • Vol: 26,902,257

Top Losing Stocks

Coterra Energy
CTRA • Vol: 73,319,495
APA
APA • Vol: 4,400,255
New Pluto Global
PSKY • Vol: 18,873,941
Costco
COST • Vol: 4,545,300
Cincinnati Financial
CINF • Vol: 2,196,176